Pyxis Oncology, Inc. (PYXS) Misses Q4 EPS by 95c
Tweet
Share
E-mailGet Alerts PYXS Hot Sheet
Join SI Premium – FREE
Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q4 EPS of ($1.28), $0.95 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $13.9 million.
For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: U.S. will enforce 'zero leakage' approach to Iran sanctions
- Broadcom credit risk measures rise amid AI financing deals
- Bessent: U.S. to end dollar access to those laundering Iran money
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
